Treatments in Women Veterans With Insomnia and PTSD
Part of paid clinical trials in West Los Angeles, California.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT05683132
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Trauma-Informed CBT-I — BEHAVIORAL5 individual sessions incorporating behavioral and cognitive therapy components and trauma-informed adaptations with a trained instructor.
- PTSD Psychoeducation — BEHAVIORAL5 individual sessions incorporating psychoeducation about PTSD symptoms with a trained instructor.
Study Details
This pilot trial will compare trauma-informed Cognitive Behavioral Therapy for Insomnia (CBT-I) to a psychoeducational intervention in women Veterans with comorbid insomnia and posttraumatic stress disorder (PTSD). The CBT-I intervention includes trauma-informed adaptations to an insomnia treatment and the psychoeducational intervention is modeled after usual care in a VA Women's Mental Health Clinic. The study objectives are to: 1) Iteratively refine the structure and materials of trauma-informed CBT-I in preparation for a pilot trial, 2) Pilot test the effects of trauma-informed CBT-I on PTSD treatment readiness and engagement in a sample of women Veterans, and 3) Examine potential mechanisms underlying variations in PTSD treatment readiness and engagement over time among women Veterans. Women Veterans with insomnia and comorbid PTSD who receive care at Sepulveda and West Los Angeles facilities will be recruited for the study. Those who pass an initial eligibility screen will be enrolled and written informed consent will be obtained. A baseline assessment will be completed that includes measures of PTSD treatment readiness, perceived barriers to PTSD treatment, and sleep and mental health symptoms. Then Veterans who meet all eligibility criteria will be randomly assigned to trauma-informed CBT-I (n=25) or the psychoeducational intervention (n=25). Both treatments will be provided in 5 one-on-one sessions by a trained instructor who is supervised by a behavioral sleep medicine specialist. All randomized participants (n=50) will have 2 follow-up assessments (post-treatment and 3-months). The follow-up assessments will collect information on PTSD treatment readiness, perceived barriers to PTSD treatment, and sleep and mental health symptoms. Chart reviews will be conducted 6-months post-treatment to assess number of PTSD treatment appointments attended (treatment engagement measure). Qualitative interviews will be conducted to identify mechanisms underlying PTSD treatment engagement.
Key Dates
- Start date
- Jun 1, 2023
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Trauma-Informed CBT-IThis intervention includes trauma-informed adaptations to standard treatment for insomnia, CBT-I
- Active Comparator: PTSD PsychoeducationThis intervention includes psychoeducation about PTSD symptoms modeled after usual care in a VA Women's Health Clinic.
Primary Outcome Measure
University of Rhode Island Change Assessment Scale (URICA) [ Time Frame: Post-Treatment (approximately 1 week after last intervention session) ]
Central Contacts
- Gwendolyn C Carlson, PhD(818) 891-7711
- Michael K Ong, MD PhD(310) 478-3711
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| VA Greater Los Angeles Healthcare System, West Los Angeles, CA | West Los Angeles | California | 90073-1003 | Gwendolyn C Carlson, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in West Los Angeles, CA
Related Studies
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Local Participatory Systems Dynamics to Increase Reach of Evidence Based Addiction and Mental Health CareEnrolling By Invitation · Palo Alto Veterans Institute for Research · Palo Alto, California
- Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)PHASE2 · Recruiting · VA Office of Research and Development · Tuscaloosa, Alabama
- Intracranial Neurophysiological Signatures of Fear and Anxiety in HumansRecruiting · Duke University · Los Angeles, California